PTX 1.30% 3.9¢ prescient therapeutics limited

updated chart, page-3214

  1. 409 Posts.
    lightbulb Created with Sketch. 208
    Thanks Big Daniel. I agree with your assessment and hope December is a transformative month for PTX.

    I find I amazing that PTX’s market cap is still only 10% of IMU’s. My only explanation for this 90% discount is that PTX has much lower liquidity in its stock, no institutional shareholder support and therefore primarily traded by retail investors.

    Given the probable short time line until a US FDA registration study for PTX-100 and the rosy prospects of commercializtion of CellPryme as its use in a rapidly growing CAR-T industry expands, I would expect this discount to narrow significantly next year.
    Last edited by Edson: 04/12/23
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.001(1.30%)
Mkt cap ! $31.40M
Open High Low Value Volume
3.9¢ 3.9¢ 3.7¢ $23.65K 615.0K

Buyers (Bids)

No. Vol. Price($)
3 564695 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 26186 2
View Market Depth
Last trade - 15.59pm 03/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.